Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma.

Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Pedersen LB, Geisler CH, Jerkeman M, Grønbæk K.

Haematologica. 2018 Nov;103(11):e541-e543. doi: 10.3324/haematol.2018.194399. Epub 2018 May 24. No abstract available.

2.

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial.

Jerkeman M, Eskelund CW, Hutchings M, Räty R, Wader KF, Laurell A, Toldbod H, Pedersen LB, Niemann CU, Dahl C, Kuitunen H, Geisler CH, Grønbæk K, Kolstad A.

Lancet Haematol. 2018 Mar;5(3):e109-e116. doi: 10.1016/S2352-3026(18)30018-8. Epub 2018 Jan 29.

PMID:
29396091
3.

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.

Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB, Montano-Almendras CP, Husby S, Freiburghaus C, Ek S, Pedersen A, Niemann C, Räty R, Brown P, Geisler CH, Andersen MK, Guldberg P, Jerkeman M, Grønbæk K.

Blood. 2017 Oct 26;130(17):1903-1910. doi: 10.1182/blood-2017-04-779736. Epub 2017 Aug 17.

PMID:
28819011
4.

Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.

Kolonen A, Sinisalo M, Huttunen R, Syrjänen J, Aittoniemi J, Huhtala H, Sankelo M, Rintala H, Räty R, Jantunen E, Nousiainen T, Säily M, Kauppila M, Itälä-Remes M, Ollikainen H, Rauhala A, Koistinen P, Elonen E; Finnish Leukemia Group.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):799-808. doi: 10.1080/23744235.2017.1347814. Epub 2017 Jul 6.

PMID:
28683646
5.

A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.

Roininen S, Laine O, Kauppila M, Vesanen M, Rämet M, Sinisalo M, Jantunen E, Säily M, Räty R, Elonen E, Wartiovaara-Kautto U.

Cancer Med. 2017 Jun;6(6):1275-1285. doi: 10.1002/cam4.1094. Epub 2017 May 15.

6.

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.

Kolstad A, Pedersen LB, Eskelund CW, Husby S, Grønbæk K, Jerkeman M, Laurell A, Räty R, Elonen E, Andersen NS, Brown PD, Kimby E, Bentzen H, Sundström C, Ehinger M, Karjalainen-Lindsberg ML, Delabie J, Ralfkiær E, Fagerli UM, Nilsson-Ehle H, Lauritzsen GF, Kuittinen O, Niemann C, Geisler CH; Nordic Lymphoma Group.

Biol Blood Marrow Transplant. 2017 Mar;23(3):428-435. doi: 10.1016/j.bbmt.2016.12.634. Epub 2016 Dec 27.

7.

15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.

Eskelund CW, Kolstad A, Jerkeman M, Räty R, Laurell A, Eloranta S, Smedby KE, Husby S, Pedersen LB, Andersen NS, Eriksson M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Workman CT, Garde C, Elonen E, Brown P, Grønbaek K, Geisler CH.

Br J Haematol. 2016 Nov;175(3):410-418. doi: 10.1111/bjh.14241. Epub 2016 Jul 5.

PMID:
27378674
8.

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma.

Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Grønbæk K, Sundberg J, Pedersen LB, Ralfkiær E, Karjalainen-Lindsberg ML, Sundström C, Ehinger M, Geisler C, Jerkeman M.

Blood. 2016 Oct 6;128(14):1814-1820. doi: 10.1182/blood-2016-03-704023. Epub 2016 Jun 27.

PMID:
27354719
9.

Understanding consistencies and gaps between desired forest futures: An analysis of visions from stakeholder groups in Sweden.

Sandström C, Carlsson-Kanyama A, Lindahl KB, Sonnek KM, Mossing A, Nordin A, Nordström EM, Räty R.

Ambio. 2016 Feb;45 Suppl 2:100-8. doi: 10.1007/s13280-015-0746-5.

10.

Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.

Hoster E, Geisler CH, Doorduijn J, van der Holt B, Walewski J, Bloehdorn J, Ribrag V, Salles G, Hallek M, Pott C, Szymczyk M, Kolstad A, Laurell A, Räty R, Jerkeman M, Van't Veer M, Kluin-Nelemans JC, Klapper W, Unterhalt M, Dreyling M, Hermine O.

Leukemia. 2016 Jun;30(6):1428-30. doi: 10.1038/leu.2015.322. Epub 2015 Nov 24. No abstract available.

PMID:
26598017
11.

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.

Husby S, Ralfkiaer U, Garde C, Zandi R, Ek S, Kolstad A, Jerkeman M, Laurell A, Räty R, Pedersen LB, Pedersen A, Ehinger M, Sundström C, Karjalainen-Lindsberg ML, Delabie J, Clasen-Linde E, Brown P, Cowland JB, Workman CT, Geisler CH, Grønbæk K.

Blood. 2015 Apr 23;125(17):2669-77. doi: 10.1182/blood-2014-06-584193. Epub 2015 Mar 3.

PMID:
25736311
12.

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.

Nordström L, Sernbo S, Eden P, Grønbaek K, Kolstad A, Räty R, Karjalainen ML, Geisler C, Ralfkiaer E, Sundström C, Laurell A, Delabie J, Ehinger M, Jerkeman M, Ek S.

Br J Haematol. 2014 Jul;166(1):98-108. doi: 10.1111/bjh.12854. Epub 2014 Mar 29.

13.

Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.

Kolstad A, Laurell A, Jerkeman M, Grønbæk K, Elonen E, Räty R, Pedersen LB, Loft A, Bogsrud TV, Kimby E, Hansen PB, Fagerli UM, Nilsson-Ehle H, Lauritzsen GF, Lehmann AK, Sundstrom C, Karjalainen-Lindsberg ML, Ralfkiaer E, Ehinger M, Delabie J, Bentzen H, Schildt J, Kostova-Aherdan K, Frederiksen H, Brown Pde N, Geisler CH; Nordic Lymphoma Group.

Blood. 2014 May 8;123(19):2953-9. doi: 10.1182/blood-2013-12-541953. Epub 2014 Mar 20.

14.

High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial.

Laurell A, Kolstad A, Jerkeman M, Räty R, Geisler CH.

Leuk Lymphoma. 2014 May;55(5):1206-8. doi: 10.3109/10428194.2013.825906. Epub 2013 Aug 28. No abstract available.

PMID:
23876100
15.

MicroRNA profiling in chemoresistant and chemosensitive acute myeloid leukemia.

Mosakhani N, Räty R, Tyybäkinoja A, Karjalainen-Lindsberg ML, Elonen E, Knuutila S.

Cytogenet Genome Res. 2013;141(4):272-6. doi: 10.1159/000351219. Epub 2013 May 16.

PMID:
23689423
16.

Targeted resequencing of 9p in acute lymphoblastic leukemia yields concordant results with array CGH and reveals novel genomic alterations.

Sarhadi VK, Lahti L, Scheinin I, Tyybäkinoja A, Savola S, Usvasalo A, Räty R, Elonen E, Ellonen P, Saarinen-Pihkala UM, Knuutila S.

Genomics. 2013 Sep;102(3):182-8. doi: 10.1016/j.ygeno.2013.01.001. Epub 2013 Jan 16.

17.

Objective cure rates and patient satisfaction after the transobturator tape procedure during 6.5-year follow-up.

Heinonen P, Ala-Nissilä S, Räty R, Laurikainen E, Kiilholma P.

J Minim Invasive Gynecol. 2013 Jan-Feb;20(1):73-8. doi: 10.1016/j.jmig.2012.09.007.

PMID:
23312245
18.

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.

Geisler CH, Kolstad A, Laurell A, Jerkeman M, Räty R, Andersen NS, Pedersen LB, Eriksson M, Nordström M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E; Nordic Lymphoma Group.

Br J Haematol. 2012 Aug;158(3):355-62. doi: 10.1111/j.1365-2141.2012.09174.x. Epub 2012 May 29. Erratum in: Br J Haematol. 2012 Sep;158(6):815-6.

PMID:
22640180
19.

Integrated analysis of gene copy number, copy neutral LOH, and microRNA profiles in adult acute lymphoblastic leukemia.

Ninomiya S, Tyybäkinoja A, Borze I, Räty R, Saarinen-Pihkala UM, Usvasalo A, Elonen E, Knuutila S.

Cytogenet Genome Res. 2012;136(4):246-55. doi: 10.1159/000337297. Epub 2012 Mar 28.

20.

Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group.

Räty R, Honkanen T, Jantunen E, Jyrkkiö S, Karjalainen-Lindsberg ML, Kuittinen O, Lehto M, Mikkola M, Poikonen E, Rauhala A, Rimpiläinen J, Räsänen A, Siitonen S, Suominen M, Vapaatalo M, Elonen E.

Leuk Lymphoma. 2012 Oct;53(10):1920-8. doi: 10.3109/10428194.2012.672736. Epub 2012 Apr 23.

PMID:
22397313
21.

Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters.

Syrjälä H, Ohtonen P, Kinnunen U, Räty R, Elonen E, Nousiainen T, Jantunen E, Remes K, Itälä-Remes M, Silvennoinen R, Koistinen P; Finnish Leukemia Group.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1211-8. doi: 10.1007/s10096-010-0984-1. Epub 2010 Jun 17.

PMID:
20556469
22.

Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data.

Usvasalo A, Elonen E, Saarinen-Pihkala UM, Räty R, Harila-Saari A, Koistinen P, Savolainen ER, Knuutila S, Hollmén J.

Leuk Res. 2010 Nov;34(11):1476-82. doi: 10.1016/j.leukres.2010.02.031. Epub 2010 Mar 19.

PMID:
20303590
23.

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

Geisler CH, Kolstad A, Laurell A, Räty R, Jerkeman M, Eriksson M, Nordström M, Kimby E, Boesen AM, Nilsson-Ehle H, Kuittinen O, Lauritzsen GF, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E; Nordic Lymphoma Group.

Blood. 2010 Feb 25;115(8):1530-3. doi: 10.1182/blood-2009-08-236570. Epub 2009 Dec 23.

PMID:
20032504
24.

Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single-nucleotide polymorphism microarray analyses.

Usvasalo A, Ninomiya S, Räty R, Hollmén J, Saarinen-Pihkala UM, Elonen E, Knuutila S.

Genes Chromosomes Cancer. 2010 Apr;49(4):309-18. doi: 10.1002/gcc.20741.

PMID:
20013897
25.

Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?

Geisler C, Kolstad A, Laurell A, Räty R, Nordic Lymphoma Group, Mantle Cell Lymphoma Subcommittee.

Leuk Lymphoma. 2009 Aug;50(8):1249-56. doi: 10.1080/10428190903040030. Review.

PMID:
19562619
26.

Acute lymphoblastic leukemias with normal karyotypes are not without genomic aberrations.

Usvasalo A, Räty R, Harila-Saari A, Koistinen P, Savolainen ER, Vettenranta K, Knuutila S, Elonen E, Saarinen-Pihkala UM.

Cancer Genet Cytogenet. 2009 Jul;192(1):10-7. doi: 10.1016/j.cancergencyto.2009.02.015.

PMID:
19480931
27.

Acute lymphoblastic leukemia in adolescents and young adults in Finland.

Usvasalo A, Räty R, Knuutila S, Vettenranta K, Harila-Saari A, Jantunen E, Kauppila M, Koistinen P, Parto K, Riikonen P, Salmi TT, Silvennoinen R, Elonen E, Saarinen-Pihkala UM.

Haematologica. 2008 Aug;93(8):1161-8. doi: 10.3324/haematol.12466. Epub 2008 Jun 12.

28.

Respiratory viruses in laryngeal croup of young children.

Rihkanen H, Rönkkö E, Nieminen T, Komsi KL, Räty R, Saxen H, Ziegler T, Roivainen M, Söderlund-Venermo M, Beng AL, Hovi T, Pitkäranta A.

J Pediatr. 2008 May;152(5):661-5. doi: 10.1016/j.jpeds.2007.10.043. Epub 2008 Jan 22. Erratum in: J Pediatr. 2008 Jul;153(1):151. Anne, Lahtinen [corrected to Beng, Anne Lahtinen].

PMID:
18410770
29.

CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study.

Usvasalo A, Savola S, Räty R, Vettenranta K, Harila-Saari A, Koistinen P, Savolainen ER, Elonen E, Saarinen-Pihkala UM, Knuutila S.

Leuk Res. 2008 Aug;32(8):1228-35. doi: 10.1016/j.leukres.2008.01.014. Epub 2008 Mar 6.

PMID:
18328560
30.

Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.

Koistinen P, Räty R, Itälä M, Jantunen E, Koivunen E, Nousiainen T, Pelliniemi TT, Remes K, Ruutu T, Savolainen ER, Siitonen T, Silvennoinen R, Volin L, Elonen E; Finnish Leukaemia Group.

Eur J Haematol. 2007 Jun;78(6):477-86. Epub 2007 Mar 28.

PMID:
17391337
31.

Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma.

Harju TH, Leinonen M, Nokso-Koivisto J, Korhonen T, Räty R, He Q, Hovi T, Mertsola J, Bloigu A, Rytilä P, Saikku P.

Thorax. 2006 Jul;61(7):579-84. Epub 2006 Mar 3.

32.

Aetiology of community-acquired pneumonia: serological results of a paediatric survey.

Don M, Fasoli L, Paldanius M, Vainionpää R, Kleemola M, Räty R, Leinonen M, Korppi M, Tenore A, Canciani M.

Scand J Infect Dis. 2005;37(11-12):806-12.

PMID:
16308213
33.

Presence of viral and bacterial pathogens in the nasopharynx of otitis-prone children. A prospective study.

Pitkäranta A, Roivainen M, Blomgren K, Peltola J, Kaijalainen T, Räty R, Ziegler T, Rönkkö E, Hatakka K, Korpela R, Poussa T, Leinonen M, Hovi T.

Int J Pediatr Otorhinolaryngol. 2006 Apr;70(4):647-54. Epub 2005 Sep 27.

PMID:
16198005
34.

Outcome of progressive disease after autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a nation-wide survey.

Kuittinen T, Wiklund T, Remes K, Elonen E, Lehtinen T, Kuittinen O, Leppä S, Putkonen M, Räty R, Turpeenniemi-Hujanen T, Nousiainen T, Jantunen E.

Eur J Haematol. 2005 Sep;75(3):199-205.

PMID:
16104875
35.

Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR.

Räty R, Rönkkö E, Kleemola M.

J Med Microbiol. 2005 Mar;54(Pt 3):287-91.

PMID:
15713613
36.

The value of virus serology in epidemiological studies of acute otitis media in children.

Räty R, Ziegler T, Kleemola M.

J Clin Virol. 2004 Apr;29(4):315-9.

PMID:
15018861
37.

Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media.

Nokso-Koivisto J, Räty R, Blomqvist S, Kleemola M, Syrjänen R, Pitkäranta A, Kilpi T, Hovi T.

J Med Virol. 2004 Feb;72(2):241-8.

PMID:
14695665
38.

Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.

Räty R, Anttila L, Virtanen A, Koskinen P, Laitinen P, Mörsky P, Tiitinen A, Martikainen H, Ekblad U.

Prenat Diagn. 2003 Dec 30;23(13):1045-8.

PMID:
14691989
39.

Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma.

Räty R, Franssila K, Jansson SE, Joensuu H, Wartiovaara-Kautto U, Elonen E.

Eur J Cancer. 2003 Feb;39(3):321-9.

PMID:
12565984
40.

Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma.

Zhu Y, Hollmén J, Räty R, Aalto Y, Nagy B, Elonen E, Kere J, Mannila H, Franssila K, Knuutila S.

Br J Haematol. 2002 Dec;119(4):905-15.

PMID:
12472567
41.

Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma.

Räty R, Franssila K, Joensuu H, Teerenhovi L, Elonen E.

Eur J Haematol. 2002 Jul;69(1):11-20.

PMID:
12270057
42.

Serum free beta-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome.

Räty R, Virtanen A, Koskinen P, Anttila L, Forsström J, Laitinen P, Mörsky P, Tiitinen A, Ekblad U.

Hum Reprod. 2002 Feb;17(2):481-4.

PMID:
11821299
43.

Maternal serum beta-hCG levels in screening for Down syndrome are higher in singleton pregnancies achieved with ovulation induction and intrauterine insemination than in spontaneous singleton pregnancies.

Räty R, Virtanen A, Koskinen P, Anttila L, Laitinen P, Tiitinen A, Ekblad U.

Fertil Steril. 2001 Nov;76(5):1075-7. No abstract available.

PMID:
11704143
44.

Detection of Mycoplasma pneumoniae by polymerase chain reaction in middle ear fluids from infants with acute otitis media.

Räty R, Kleemola M.

Pediatr Infect Dis J. 2000 Jul;19(7):666-8. No abstract available.

PMID:
10917232
45.

Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies.

Räty R, Virtanen A, Koskinen P, Laitinen P, Forsström J, Salonen R, Mörsky P, Ekblad U.

Prenat Diagn. 2000 Mar;20(3):221-3.

PMID:
10719325
46.

Efficacy of PCR and other diagnostic methods for the detection of respiratory adenoviral infections.

Räty R, Kleemola M, Melén K, Stenvik M, Julkunen I.

J Med Virol. 1999 Sep;59(1):66-72.

PMID:
10440810
47.

Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.

Räty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U.

Prenat Diagn. 1999 Feb;19(2):122-7.

PMID:
10215068
48.

Detection of antibodies to Mycoplasma pneumoniae adhesion P1 in serum specimens from infected and non-infected subjects by immunoblotting.

Rastawicki W, Räty R, Kleemola M.

Diagn Microbiol Infect Dis. 1996 Nov-Dec;26(3-4):141-3.

PMID:
9078450
49.

Evaluation of an antigen-capture enzyme immunoassay for rapid diagnosis of Mycoplasma pneumoniae infection.

Kleemola M, Räty R, Karjalainen J, Schuy W, Gerstenecker B, Jacobs E.

Eur J Clin Microbiol Infect Dis. 1993 Nov;12(11):872-5.

PMID:
8112363
50.

Supplemental Content

Support Center